MC
SPPI

Moors & Cabot’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Moors & Cabot’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,400
Closed -$9.3K – 932
2023
Q1 		$9.3K Buy
12,400
+2,400
+24% +$1.75K ﹤0.01% 839
2022
Q4 		$3.69K Sell
10,000
-2,400
-19% -$1.01K ﹤0.01% 840
2022
Q3 		$5K Buy
+12,400
New +$12.2K ﹤0.01% 811

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moors & Cabot's SPPI Position: Q2 2023 in Review

Moors & Cabot sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2023, closing a stake of 12,400 shares — an estimated $9.3K sold.

Moors & Cabot first reported a position in SPPI in Q3 2022 and held it in 3 quarters. The position peaked at $9.3K in Q1 2023. 78 funds tracked by Wall St. Rank hold SPPI as of Q2 2023.

  • Moors & Cabot reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2023 after selling out during the quarter.
  • Moors & Cabot sold 12,400 Spectrum Pharmaceuticals Inc shares in Q2 2023, an estimated $9.3K.
  • Moors & Cabot first reported a position in Spectrum Pharmaceuticals Inc in Q3 2022 and held it in 3 quarters.
  • Moors & Cabot's Spectrum Pharmaceuticals Inc position peaked at $9.3K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2023.

Based on Moors & Cabot's 13F filing for Q2 2023, filed 10 Aug 2023.